PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Sabbagh, Marwan
TI  - Negative Florbetaben PET Scan Excludes the Presence of Amyloid Pathology
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 9--10
VI  - 14
IP  - 6
4099  - http://mdc.sagepub.com/content/14/6/9.2.short
4100  - http://mdc.sagepub.com/content/14/6/9.2.full
AB  - There is a strong correlation between florbetaben (an F-labeled β-amyloid-targeted tracer) uptake and amyloid pathology. This article presents results of the Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-Amyloid Compared to Histopathology trial (ClinicalTrials.gov identifier NCT01020838). These results support the use of florbetaben as a valuable diagnostic tool for the exclusion of Alzheimer's disease or differential diagnosis of dementia as the cause of cognitive decline.